Skip to main content
×
×
Home

The Neurobiology of Substance and Behavioral Addictions

  • Jon E. Grant, Judson A. Brewer and Marc N. Potenza
Abstract

Behavioral addictions, such as pathological gambling, kleptomania, pyromania, compulsive buying, and compulsive sexual behavior, represent significant public health concerns and are associated with high rates of psychiatric comorbidity and mortality. Although research into the biology of these behaviors is still in the early stages, recent advances in the understanding of motivation, reward, and addiction have provided insight into the possible pathophysiology of these disorders. Biochemical, functional neuroimaging, genetic studies, and treatment research have suggested a strong neurobiological link between behavioral addictions and substance use disorders. Given the substantial co-occurrence of these groups of disorders, improved understanding of their relationship has important implications not only for further understanding the neurobiology of both categories of disorders but also for improving prevention and treatment strategies.

Copyright
Corresponding author
Please direct all correspondence to: Jon E. Grant, JD, MD, MPH, University of Minnesota Medical School, 2450 Riverside Avenue, Minneapolis, MN 55454; Tel: 612-273-9736, Fax: 612-273-9779; E-mail: grant045@umn.edu.
References
Hide All
1.Holden, C. ‘Behavioral’ addictions: do they exist? Science. 2001;294:980982.
2.Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text revision. Washington, DC: American Psychiatric Association; 2000.
3.Grant, JE, Potenza, MN. Pathological gambling and other behavioral addictions. In: Frances, RJ, Miller, SI, Mack, AH, eds. Clinical Textbook of Addictive Disorders. 3rd ed. New York: Guildford Press; 2005:303320.
4.Blanco, C, Moreyra, P, Nunes, EV, Saiz-Ruiz, J, Ibanez, A. Pathological gambling: addiction or compulsion? Semin Clin Neuropsychiatry. 2001;6:167176.
5.Potenza, MN. Should addictive disorders include non-substance-related conditions? Addiction. 2006;101(suppl 1):142151.
6.Chambers, RA, Potenza, MN. Neurodevelopment, impulsivity, and adolescent gambling. J Gambl Stud. 2003;19:5384.
7.Potenza, MN, Kosten, TR, Rounsaville, BJ. Pathological gambling. JAMA. 2001;286:141144.
8.Crockford, DN, el-Guebaly, N. Psychiatric comorbidity in pathological gambling: a critical review. Can J Psychiatry. 1998;43:4350.
9.Petry, NM, Stinson, FS, Grant, BF. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66:564574.
10.McCormick, RA, Russo, AM, Ramirez, LF, Taber, JI. Affective disorders among pathological gamblers seeking treatment. Am J Psychiatry. 1984;141:215218.
11.Cunningham-Williams, RM, Cottler, LB, Compton, WM III, Spitznagel, EL. Taking chances: Problem gamblers and mental health disorders-results from the St. Louis Epidemiologic Catchment Area study. Am J Pub Health. 1998;88:10931096.
12.Spunt, B, Lesieur, H, Hunt, D, Cahill, L. Gambling among methadone patients. Int J Addict. 1995;30:929962.
13.Grant, JE, Kim, SW. Clinical characteristics and associated psychopathology of 22 patients with kleptomania. Compr Psychiatry. 2002;43:378384.
14.McElroy, SL, Pope, HG, Hudson, JI, Keck, PE, White, KL. Kleptomania: a report of 20 cases. Am J Psychiatry. 1991;148:652657.
15.Christenson, GA, Faber, RJ, de Zwaan, M, et al.Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry. 1994;55:511.
16.Schlosser, S, Black, DW, Repertinger, S, Freet, D. Compulsive buying: demography, phenomenology, and comorbidity in 46 subjects. Gen Hosp Psychiatry. 1994;16:205212.
17.Potenza, MN. The neurobiology of pathological gambling. Semin Clin Neuropsychiatry. 2001;6:217226.
18.Benkelfat, C, Murphy, DL, Hill, JL, George, DT, Nutt, D, Linnoila, M. Ethanollike properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients. Arch Gen Psychiatry. 1991;48:383.
19.Kalivas, PW, Volkow, ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005;162:14031413.
20.Bergh, C, Eklund, T, Sodersten, P, Nordin, C. Altered dopamine function in pathological gambling. Psychol Med. 1997;27:473475.
21.Blum, K, Cull, JG, Braverman, ER, Comings, DE. Reward deficiency syndrome. Am Scientist. 1996;84:132145.
22.Nestler, E, Aghajanian, GK. Molecular and cellular basis of addiction. Science. 1997;278:5862.
23.Chambers, RA, Taylor, JR, Potenza, MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry. 2003;160:10411052.
24.Loba, P, Stewart, SH, Klein, RM, Blackburn, JR. Manipulations of the features of standard video lottery terminal (VLT) games: effects in pathological and non-pathological gamblers. J Gambl Stud. 2001;17:297320.
25.Zack, M, Poulos, CX. Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers. Neuropsychopharmacol. 2004;29:195207.
26.Dackis, C, O'Brien, C. Neurobiology of addiction: treatment and public policy ramifications. Nat Neurosci. 2005;8:14311436.
27.Grant, JE, Potenza, MN, Hollander, E, et al.A multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry. 2006;163:303312.
28.Grant, JE, Kim, SW. An open label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry. 2002;63:349356.
29.Kim, SW, Grant, JE, Adson, D, Shin, YC. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry. 2001;49:914921.
30.Volpicelli, JR, Alterman, AI, Hayashida, M, O'Brien, CP. Naltrexone in the treatment of alcohol dependence Arch Gen Psychiatry. 1992;49:876880.
31.Mason, BJ, Salvato, FR, Williams, LD, Ritvo, EC, Cutler, RB. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch Gen Psychiatry. 1999;56:719724.
32.Schmitt, LH, Harrison, GA, Spargo, RM. Variation in epinephrine and cortisol excretion rates associated with behavior in an Australian Aboriginal community. Am J Phys Anthropol. 1998;106:249253.
33.Ramirez, LF, McCormick, RA, Lowy, MT. Plasma cortisol and depression in pathological gamblers. Br J Psychiatry. 1988;153:684686.
34.Roy, A, Adinoff, B, Roehrich, L, et al.Pathological gambling. A psychobiological study. Arch Gen Psychiatry. 1988;45:369373.
35.Meyer, G, Hauffa, BP, Schedlowski, M, Pawlak, C, Stadler, MA, Exton, MS. Casino gambling increases heart rate and salivary cortisol in regular gamblers. Biol Psychiatry. 2000;48:948953.
36.Krueger, THC, Schedlowski, M, Meyer, G. Cortisol and heart rate measures during casino gambling in relation to impulsivity. Neuropsychobiology. 2005;52:206211.
37.Meyer, G, Schwertfeger, J, Exton, MS, et al.Neuroendocrine response to casino gambling in problem gamblers. Psychoneuroendocrinology. 2004;29:12721280.
38.Potenza, MN, Steinberg, MA, Skudlarski, P, et al.Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch Gen Psychiatry. 2003;60:828836.
39.Potenza, MN, Leung, HC, Blumberg, HP, et al.An FMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry. 2003;160:19901994.
40.Reuter, J, Raedler, T, Rose, M, Hand, I, Glascher, J, Buchel, C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci. 2005;8:147148.
41.London, ED, Ernst, M, Grant, S, Bonson, K, Weinstein, A. Orbitofrontal cortex and human drug abuse: functional imaging. Cereb Cortex. 2000;10:334342.
42.Bechara, A. Risky business: emotion, decision-making, and addiction. J Gambl Stud. 2003;19:2351.
43.Lim, KO, Choi, SJ, Pomara, N, Wolkin, A, Rotrosen, JP. Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol Psychiatry. 2002;51:890895.
44.Grant, JE, Correia, S, Brennan-Krohn, T. White matter integrity in kleptomania: a pilot study. Psychiatry Res Neuroimaging. 2006;147:233237. Epub 2006 Sep 7.
45.Hollander, E, Pallanti, S, Baldini Rossi, N, Sood, E, Baker, BR, Buchsbaum, MS. Imaging monetary reward in pathological gamblers. World J Biol Psychiatry. 2005;6:113120.
46.Crockford, DN, Goodyear, B, Edwards, J, Quickfall, J, el-Guebaly, N. Cue-induced brain activity in pathological gamblers. Biol Psychiatry. 2005;58:787795.
47.Cavedini, P, Riboldi, G, Keller, R, D'Annucci, A, Bellodi, L. Frontal lobe dysfunction in pathological gambling patients. Biol Psychiatry. 2002;51:334341.
48.Petry, NM. Pathological Gambling: Etiology, Comorbidity, and Treatment. Washington, DC: American Psychological Association; 2005.
49.Rugle, L, Melamed, L. Neuropsychological assessment of attention problems in pathological gamblers. J Nerv Ment Dis. 1993;181:107112.
50.Specker, SM, Carlson, GA, Christenson, GA, Marcotte, M. Impulse control disorders and attention deficit disorder in pathological gamblers. Ann Clin Psychiatry. 1995;7:175179.
51.Diskin, KM, Hodgins, DC. Narrowing of attention and dissociation in pathological video lottery gamblers. J Gambl Stud. 2000;16:461467.
52.Goudriaan, AE, Oosterlaan, J, de Beurs, E, van den Brink, W. Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction. 2006;101:534547
53.Kertzman, S, Lowengrub, K, Aizer, A, Ben Nahum, Z, Kotler, M, Dannon, PN. Stroop performance in pathological gamblers. Psychiatry Res. 2006;142:110.
54.Grant, JE, Odlaug, BL, Wozniak, JR. Neuropsychological functioning in kleptomania. Behav Res Ther. 2006 Sep 26: [Epub ahead of print].
55.Shah, KR, Potenza, MN, Eisen, SA. Biological basis for pathological gambling. In Grant, JE, Potenza, MN, eds. Pathological Gambling: A Clinical Guide to Treatment. Washington DC: American Psychiatric Publishing, Inc; 2004:127142.
56.Potenza, MN, Xian, H, Shah, K, Scherrer, JF, Eisen, SA. Shared genetic contributions to pathological gambling and major depression in men. Arch Gen Psychiatry. 2005;62:10151021.
57.Comings, DE, Rosenthal, RJ, Lesieur, HR, et al.A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics. 1996;6:223234.
58.Comings, DE, Gade, R, Wu, S, et al.Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry. 1997;2:4456.
59.Comings, DE, Gonzalez, N, Wu, S, et al.Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am J Med Genet. 1999;88:358368.
60.Perez de Castro, I, Ibanez, A, Torres, P, Saiz-Ruiz, J, Fernandez-Piqueras, J. Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene. Pharmacogenetics. 1997;7:345348.
61.O'Brien, CP, McKay, J. Pharmacological treatments for substance use disorders. In: Nathan, PE, Gorman, JM, eds. A Guide to Treatments that Work. 2nd ed. New York, NY: Oxford University Press: 2002:125156.
62.Grant, JE, Potenza, MN. Impulse control disorders: clinical characteristics and pharmacological management. Ann Clin Psychiatry. 2004;16:2734.
63.Oslin, DW, Berrettini, W, Kranzler, HR, et al.A functional polymorphism of the muopioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology. 2003;28:15461552.
64.Potenza, MN. Impulse control disorders and co-occurring disorders: dual diagnosis considerations. Journal of Dual Diagnosis. In press.
65.Hollander, E, Kaplan, A, Pallanti, S. Pharmacological treatments. In: Grant, JE, Potenza, MN. Pathological Gambling: A Clinical Guide to Treatment. Washington DC: American Psychiatric Publishing, Inc. 2004:189206.
66.Hollander, E, DeCaria, CM, Finkell, JN, Begaz, T, Wong, CM, Cartwright, C. A randomized double-blind fluvoxamine/placebo crossover trial in pathological gambling. Biol Psychiatry. 2000;47:813817.
67.Hollander, E, Pallanti, S, Allen, A, Sood, E, Baldini Rossi, N. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry. 2005;162:137146.
68.Grant, JE, Potenza, MN. Escitalopram in the treatment of pathological gambling with co-occurring anxiety: An open-label study with double-blind discontinuation. Int Clin Psychopharmacol. 2006;21:203209.
69.Black, DW. An open-label trial of bupropion in the treatment of pathologic gambling. J Clin Psychopharmacol. 2004;24:108110.
70.Stein, DJ, Lochner, C. Obsessive compulsive spectrum disorders: a multidimensional approach. Psychiatr Clin N Am. 2006;29:343351.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

CNS Spectrums
  • ISSN: 1092-8529
  • EISSN: 2165-6509
  • URL: /core/journals/cns-spectrums
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 167 *
Loading metrics...

Abstract views

Total abstract views: 1565 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 16th August 2018. This data will be updated every 24 hours.